Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...

Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...

Protagonist Therapeutics (NASDAQ:PTGX) and Takeda (NYSE:TAK) said on Monday that its late-stage study of rusfertide for the ...

周一，H.C. Wainwright分析师Douglas Tsao将Protagonist ...

Lazarus is Shinichiro Watanabe's long-awaited next anime project, and his collaboration with John Wick director Chad ...

根据 InvestingPro 分析，在市值23亿美元、财务状况优秀的生物科技公司Protagonist Therapeutics, Inc. (NASDAQ: PTGX )近期的一项交易中，总裁兼首席执行官Dinesh V.

Dragon Ball Super manga introduced Beast Gohan in Chaṕter 99 ("Son Gohan's Ultimate Awakening!"), while adapting the Super ...

Solo Leveling anime series has made a major modification with Sung Jinwoo's character which will enhance his development as a ...